News Releases

Latest News Releases

10/22/26
Neurocrine Biosciences Announces Publication in Orphanet Journal of Rare Diseases Advancing Understanding of Hyperphagia in Prader-Willi Syndrome
10/20/26
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-'567 in Adults with Alzheimer's Disease
10/16/26
Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia
10/12/26
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
9/30/26
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
9/28/26
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer